Načítá se...
Tuberculosis Vaccine Development: Progress in Clinical Evaluation
Tuberculosis (TB) is the leading killer among all infectious diseases worldwide despite extensive use of the Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine. A safer and more effective vaccine than BCG is urgently required. More than a dozen TB vaccine candidates are under active evaluatio...
Uloženo v:
| Vydáno v: | Clin Microbiol Rev |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6822991/ https://ncbi.nlm.nih.gov/pubmed/31666281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CMR.00100-19 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|